Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-03

Clinical Trial Update: Safety and Efficacy Study of Anucort HC TM 25mg Rectal Suppositories to Treat Symptomatic Internal Hemorrhoids [Phase 2]

View source ↗

Summary

Completed Phase 2 safety and efficacy trial of Anucort HC 25 mg rectal suppositories for symptomatic internal hemorrhoids.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anucort HC (hydrocortisone acetate)

Snippet

Sponsor: G & W Laboratories Inc. | Conditions: Internal Hemorrhoids | Phase 2 | Status: COMPLETED